Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, August 1, 2026

Oral Microbiota, the Oral–Brain Axis, and Neurodegeneration: Mechanisms and Dietary Modulation

 When will your competent? doctor get AN EXACT PROTOCOL ON THIS?  Incompetent ones will answer that by doing nothing!

Oral Microbiota, the Oral–Brain Axis, and Neurodegeneration: Mechanisms and Dietary Modulationpp/


by 1,*,†, 2,3,†, 4, 5, 1, 2,3, 6,7,8,9, 10, 6,11,12, 13,14,15, 16, 1,*, 13,17, 18, 6,11,12 and 1
1
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
2
Departmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy
3
IRCCS San Camillo Hospital, 30126 Venice, Italy
4
Periodontology Unit, Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London SE1 9RT, UK
5
Statistical Laboratory, Jagiellonian University Medical College, 31-126 Kraków, Poland
6
Research Group on Food, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, Isabel Torres 21, 39011 Santander, Spain
7
Universidad Internacional Iberoamericana, Campeche 24560, Mexico
8
Universidad Internacional Iberoamericana, Arecibo, PR 00613, USA
9
Fundación Universitaria Internacional de Colombia, Bogotá 111321, Colombia
10
Escuela de Medicina, Universidad Espíritu Santo, Samborondón 0901952, Ecuador
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Antioxidants 2026, 15(8), 925; https://doi.org/10.3390/antiox15080925
Submission received: 5 June 2026 / Revised: 13 July 2026 / Accepted: 20 July 2026 / Published: 25 July 2026
(This article belongs to the Special Issue Interplay of Microbiome and Oxidative Stress)

Abstract

The oral microbiota represents a complex and dynamic microbial ecosystem that plays a critical role in preserving both oral and systemic homeostasis. Emerging evidence suggests that alterations in oral microbial milieu (dysbiosis) may contribute to the pathogenesis of neurodegenerative disorders, especially Alzheimer’s disease (AD), through the oral–brain axis. This review synthesizes current evidence on the pathways linking oral microbiota to cognitive decline, integrating microbial, immunological, and vascular perspectives. Oral pathogens may access the central nervous system via hematogenous dissemination or neural routes, including the trigeminal nerve, while simultaneously promoting systemic inflammation, immune activation, and blood–brain barrier disruption. These processes converge on key neurodegenerative mechanisms, including chronic neuroinflammation, amyloid-β accumulation, and tau pathology. In parallel, alterations in oral microbial composition have been linked to disease severity, supporting a potential role of dysbiosis in both initiation and progression of cognitive impairment. Diet emerges as a critical modifiable determinant of oral microbial ecology. Diets rich in refined sugars may promote dysbiosis and inflammatory signaling, whereas (poly)phenols, probiotics, and prebiotics may support microbial eubiosis and exert neuroprotective effects through modulation of host–microbe interactions. Although current evidence remains largely observational and mechanistic, the diet–oral microbiota–brain axis represents a promising target for preventive and therapeutic strategies aimed at mitigating cognitive decline and promoting healthy aging. Future longitudinal and interventional studies are required to establish causality and translate these insights into clinical practice.

No comments:

Post a Comment